ArticleClinical cancer research : an official journal of the American Association for Cancer Research2014

Antagonism of SET using OP449 enhances the efficacy of tyrosine kinase inhibitors and overcomes drug resistance in myeloid leukemia.

Anupriya Agarwal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.